<> Aurobindo Pharma Share Price Today: Live Aurobindo Pharma Share Price NSE/BSE | 5paisa
AUROPHARMA

Aurobindo Pharma Share PriceAurobindo Pharma

₹404.2
-5.85 (-1.43%)
  • Advice
  • Hold
As on 05 February, 2023 | 19:46 BSE: 524804 NSE: AUROPHARMA

Aurobindo Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Aurobindo Pharma

Start SIP

Aurobindo Pharma Share Price

  • Over 1 Month -8.41%
  • Over 3 Month -27.61%
  • Over 6 Month -27.46%
  • Over 1 Year -39.74%

Aurobindo Pharma Key Statistics

P/E Ratio 11.2
PEG Ratio -0.2
Market Cap Cr 23,684
Price to Book Ratio 1
EPS 26.2
Dividend 1.5
Relative Strength Index 27.3
Money Flow Index 44.28
MACD Signal -8.06
Average True Range 10.85

Aurobindo Pharma Investment Rating

  • Master Rating:
  • Aurobindo Pharma has an operating revenue of Rs. 23,786.88 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of 15% is great, ROE of 10% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 42 which is a POOR score indicating inconsistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Aurobindo Pharma Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 2,9702,7352,878
Operating Expenses Qtr Cr 2,7302,5452,380
Operating Profit Qtr Cr 296242507
Depreciation Qtr Cr 109103101
Interest Qtr Cr 1985
Tax Qtr Cr 5948-63
Net Profit Qtr Cr 165122802

Aurobindo Pharma Technicals

EMA & SMA

Current Price
₹404.2
-5.85 (-1.43%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 427.42
  • 50 Day
  • 446.44
  • 100 Day
  • 474.23
  • 200 Day
  • 523.25
  • 20 Day
  • 432.53
  • 50 Day
  • 443.56
  • 100 Day
  • 480.3
  • 200 Day
  • 518.7

Aurobindo Pharma Resistance and Support

PIVOT
₹410.87
Resistance
First Resistance 413.74
Second Resistance 417.42
Third Resistance 420.29
RSI 27.3
MFI 44.28
MACD Single Line -8.06
MACD -10.93
Support
First Resistance 407.19
Second Resistance 404.32
Third Resistance 400.64

Aurobindo Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,500,926 57,830,679 38.53
Week 1,864,598 98,786,402 52.98
1 Month 1,402,581 62,863,702 44.82
6 Month 1,666,994 58,328,132 34.99

Aurobindo Pharma Result Highlights

Aurobindo Pharma Synopsis

NSE-Medical-Generic Drugs

Aurobindo Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 11287.14 Cr. and Equity Capital is Rs. 58.59 Cr. for the Year ended 31/03/2022. Aurobindo Pharma Ltd. is a Public Limited Listed company incorporated on 26/12/1986 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24239TG1986PLC015190 and registration number is 015190.
Market Cap 23,684
Sales 11,323
Shares in Float 28.12
No of funds 645
Yield 1.48
Book Value 1.38
U/D Vol ratio 0.6
LTDebt / Equity
Alpha -0.18
Beta 0.89

Aurobindo Pharma

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 51.83%51.83%51.83%
Mutual Funds 7.5%8.96%9.82%
Insurance Companies 7.15%7.26%5.76%
Foreign Portfolio Investors 22.31%21.41%20.71%
Financial Institutions/ Banks 0.01%
Individual Investors 9.42%8.64%8.8%
Others 1.79%1.89%3.08%

Aurobindo Pharma Management

Name Designation
Mr. K Ragunathan Non Executive Chairman
Mr. K Nithyananda Reddy Vice Chairman & Mng.Director
Mr. P Sarath Chandra Reddy Whole Time Director
Dr. M Sivakumaran Whole Time Director
Mr. M Madan Mohan Reddy Whole Time Director
Mr. P V Ramprasad Reddy Non Executive Director
Mrs. Savita Mahajan Ind. Non-Executive Director
Mr. Girish P Vanvari Ind. Non-Executive Director
Dr.(Mrs.) Avnit Bimal Singh Ind. Non-Executive Director

Aurobindo Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Aurobindo Pharma Corporate Action

Date Purpose Remarks
2023-02-09 Quarterly Results & Interim Dividend
2022-11-12 Quarterly Results
2022-08-11 Quarterly Results
2022-05-30 Audited Results & 4th Interim Dividend
2022-02-09 Quarterly Results & 3rd Interim Dividend
Date Purpose Remarks
2023-02-17 INTERIM Interim Dividend
2022-06-07 INTERIM Rs.4.50 per share (450%) Fourth Interim Dividend
2022-02-21 INTERIM Rs.1.50 per share(150%)Third Interim Dividend
2021-11-18 INTERIM Rs.1.50 per share (150%) Second Interim Dividend
2021-08-30 INTERIM Rs.1.50 per share(150%)Interim Dividend

Aurobindo Pharma MF Shareholding

Name Amount(cr)
HDFC Balanced Advantage Fund Growth 51027
HDFC Mid-Cap Opportunities Fund Growth 35731
SBI Bluechip Fund Regular Growth 35617
Mirae Asset Emerging Bluechip Fund Growth 24055
HDFC Top 100 Fund Growth 22703

Aurobindo Pharma FAQs

What is Share Price of Aurobindo Pharma ?

Aurobindo Pharma share price is ₹404 As on 05 February, 2023 | 19:32

What is the Market Cap of Aurobindo Pharma ?

The Market Cap of Aurobindo Pharma is ₹23683.6 Cr As on 05 February, 2023 | 19:32

What is the P/E ratio of Aurobindo Pharma ?

The P/E ratio of Aurobindo Pharma is 11.2 As on 05 February, 2023 | 19:32

What is the PB ratio of Aurobindo Pharma ?

The PB ratio of Aurobindo Pharma is 1 As on 05 February, 2023 | 19:32

Is it a good time to invest in Aurobindo Pharma?

Aurobindo Pharma has an operating revenue of Rs.24,010.31 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 30% is great. Many brokers and analysts have recommended 'Buy' on the stock.

How many times have Aurobindo Pharma given dividends since 2000?

Aurobindo Pharma Ltd. has declared 40 dividends since May 10, 2000.

What is the stock price CAGR of Aurobindo Pharma?

The stock price CAGR of Aurobindo Pharma for 10 Years is 30%, 5 Years is 0%, 3 Years is -3%, 1 Year is -25%.

What is the ROE of Aurobindo Pharma?

Aurobindo Pharma has an ROE of 24% which is exceptional.

What is Aurobindo Pharma’s debt to equity?

Aurobindo Pharma has a reasonable debt to equity of 1%, which signals a healthy balance sheet.

Q2FY23